Beta-caryophyllene synthase and application thereof in preparation of beta-caryophyllene
By expressing β-caryophyllene synthase in Saccharomyces cerevisiae, using β-caryophyllene to produce β-caryophyllene, and optimizing the metabolic pathway, the efficient production of β-caryophyllene was achieved, solving the problem of obtaining sesquiterpenes, achieving the goal of achieving High yield and efficient biosynthesis effects.
Patent Information
- Application Number
- CN202411249130.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-09-06
AI Technical Summary
It is difficult to obtain sesquiterpene compound β-caryophyllene on a large scale in the prior art. The traditional methods are complex and resource-based components are limited, so sustainable utilization solutions are needed.
By designing a β-caryophyllene synthase and transferring it into Saccharomyces cerevisiae, using acacia pyrophosphate as a substrate, β-caryophyllene is produced through engineering bacteria to build a high-yield β-caryophyllene engineering bacteria of Saccharomyces cerevisiae with high yields of β-caryophyllene. , optimize the MVA pathway to improve biosynthesis efficiency.
A high yield of β-caryophyllene was successfully obtained, with a shake flask yield of 828.4 mg/L, and a titer in the fermenter reached 15.6 g/L. It is currently the highest record in yeast, solving the problem of resource ingredient extraction and the complexity of biosynthesis.
Smart Images

Figure CN119060994A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of genetic engineering, and in particular to a beta-caryophyllene synthase and application thereof in the preparation of beta-caryophyllene. Background Art
[0002] Caryophyllene is a bicyclic sesquiterpene first discovered in 1834. It exists in essential oils, especially clove oil extracted from the dried buds of Eugenia caryophyllata Thunb., a plant of the Myrtaceae family. It has three conformations: α-, β-, and γ-. Among them, β-caryophyllene has the highest content in nature and is widely used in food, cosmetics, and biofuels. For example, β-caryophyllene is certified by the U.S. Food and Drug Administration (FDA) as a food additive and a flavoring that meets the requirements of my country's GB2760 "Standards for the Use of Food Additives" and has great potential as a substitute for aircraft fuel. In addition, β-caryophyllene also has multiple physiological activities such as anti-cancer, anti-inflammatory, antioxidant, and analgesic, and is considered to be an excellent natural analgesic and a candidate for complementary cancer treatment. Therefore, β-caryophyllene is a sesquiterpene compound that deserves to be focused on, studied, and fully developed and utilized.
[0003] Synthetic biology is an important means to solve the sustainable utilization of effective ingredients in traditional Chinese medicine. The representative substance of sesquiterpenoid compounds in mugwort is β-caryophyllene, which has significant anti-cancer activity and is widely used in clinical medicine, cosmetics and food. However, due to the limited extraction of such resource ingredients from plants and the complexity of chemical synthesis, it is not advisable to obtain sesquiterpenoids on a large scale using traditional methods. Using microbial cell factories to produce sesquiterpenoid compounds is a very promising solution. Summary of the invention
[0004] The purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art and provide a β-caryophyllene synthase.
[0005] Another object of the present invention is to provide the use of the above-mentioned β-caryophyllene synthase in the preparation of β-caryophyllene.
[0006] Another object of the present invention is to provide an engineered bacterium for producing β-caryophyllene.
[0007] The purpose of the present invention is achieved through the following technical solutions:
[0008] A β-caryophyllene synthase is at least one of:
[0009] (a) a protein consisting of an amino acid sequence as shown in at least one of SEQ ID NO.1, SEQ ID NO.3, SEQ ID NO.5 and SEQ ID NO.7;
[0010] (b) a sequence having a sequence homology of more than 90% with at least one of the amino acid sequences shown in SEQ ID NO.1, SEQ ID NO.3, SEQ ID NO.5 and SEQ ID NO.7 and having the same protein function.
[0011] The β-caryophyllene synthase can be expressed in an engineered bacterium and produce β-caryophyllene using farnesyl pyrophosphate as a substrate.
[0012] The engineered bacteria are engineered bacteria that highly express farnesyl pyrophosphate (FPP); preferably, the engineered bacteria SE-Y0.
[0013] The nucleotide sequence of the gene encoding the above-mentioned β-caryophyllene synthase is obtained according to the codon coding rule.
[0014] The β-caryophyllene synthase mentioned above has a coding gene having a nucleotide sequence shown by at least one of SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.8.
[0015] Application of the above-mentioned β-caryophyllene synthase in the production of β-caryophyllene.
[0016] A beta-caryophyllene synthase gene can be introduced into saccharomyces cerevisiae to produce beta-caryophyllene, and its amino acid sequence is at least one of SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.8.
[0017] Application of the above-mentioned β-caryophyllene synthase gene in the production of β-caryophyllene.
[0018] An engineered strain of Saccharomyces cerevisiae that produces high levels of β-caryophyllene has the following characteristics:
[0019] Using Saccharomyces cerevisiae as the starting strain, the GAL80 gene was knocked out, the tHMGR and UPC2-1 genes were introduced, the NDT80 gene was knocked out and the HIF-1α and ARNT genes were overexpressed, and the ERG20 gene and β-caryophyllene synthase gene were introduced to obtain it.
[0020] The said transfer of tHMGR and UPC2-1 genes is to integrate tHMGR and UPC2-1 genes into the TY4 site of the Saccharomyces cerevisiae chromosome.
[0021] The ERG20 gene and the beta-caryophyllene synthase gene are transferred by using (GGGS)2 as a connecting peptide to fuse the ERG20 and beta-caryophyllene synthase genes to obtain a fusion fragment, and then integrating the fusion fragment into the TY1 site of the Saccharomyces cerevisiae chromosome.
[0022] The knockout of NDT80 gene and overexpression of HIF-1α and ARNT genes is to knock out the NDT80 gene in the Saccharomyces cerevisiae genome and integrate the HIF-1α and ARNT genes into the original position of the NDT80 gene.
[0023] The brewer's yeast is an engineered bacterium SE-Y0.
[0024] A method for constructing an engineered strain of Saccharomyces cerevisiae that produces high levels of β-caryophyllene comprises the following steps:
[0025] (1) Using Saccharomyces cerevisiae as the starting strain, the GAL80 gene was knocked out to obtain strain SE-B0;
[0026] (2) The GAL1p promoter, ERG20 gene, (GGGS)2 connecting peptide, β-caryophyllene synthase gene and CYC1t terminator were sequentially connected to obtain a fusion fragment, which was integrated into the TY1 site of the genome of strain SE-B0, and strain SE-B1 was obtained after screening;
[0027] (3) The PGK1p promoter, HIF-1α gene, CYC1t terminator, TEF1p promoter, ARNT gene and ADH1t were sequentially connected to construct the PGK1p-HIF-1α-CYC1t-TEF1p-ARNT-ADH1t fragment, the NDT80 gene in the genome of strain SE-B1 was knocked out, and the fragment was integrated into the position of the original NDT80 gene. After screening, strain SE-B2 was obtained;
[0028] (4) The GAL10p promoter, tHMGR gene, ADH1t terminator, GAL1p promoter, UPC2-1 gene and CYC1t terminator were sequentially connected to construct the GAL10p-tHMGR-ADH1t-GAL1p-UPC2-1-CYC1t fragment, which was integrated into the TY4 site of strain SE-B2, and an engineered Saccharomyces cerevisiae strain with high β-caryophyllene production was obtained after screening.
[0029] The nucleotide sequence of the (GGGS)2 connecting peptide is shown in SEQ ID NO.10.
[0030] The β-caryophyllene synthase gene is a gene that can express and produce β-caryophyllene, preferably a gene corresponding to a nucleotide sequence shown in at least one of SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.8.
[0031] The brewer's yeast is an engineered bacterium SE-Y0.
[0032] The integration is to transform the fragment into the cell using the lithium acetate transformation method, and the fragment is transferred together with the positioning fragment containing the homologous fragment and the screening marker, and integrated with the target site through homologous recombination.
[0033] The engineered bacteria SE-Y0 has been disclosed in the literature Wu S, Zhang F, Xiong W, et al. An Unexpected Oxidosqualene Cyclase Active Site Architecture in the Iris tectorum Multifunctional α-Amyrin Synthase [J]. DOI: 10.1021 / acscatal.0c03231. The strain is based on CEN.PK2-1C as the starting strain, and Ptef1-ERG1-Tpgk, Padh1-ERG13-Tadh1, Padh1-ERG12-Tadh1, Ptef2-ERG19-Tcyc1, Ppgk-IDI1-Tpgk, Ptdh3-AtCPR1-Tt dh3,Ptef1-ERG10-Tpgk,Ptdh3-ERG8-Ttdh3,Ppgk-tHMGR-Tadh1,Ptdh3-ERG20+ERG9-Tcyc1,Trp site was transferred into Ptdh3-ERG20+ERG9-Tcyc1,Ptef1-ERG10-Tpgk,Ptdh3-ERG8-Ttdh3,Ppgk-tHMGR-Tadh1,Ptef1-ERG1-Tpgk1.
[0034] The nucleotide sequence of the GAL80 gene is shown in NCBI database sequence accession number 854954.
[0035] The nucleotide sequence of the tHMGR gene is shown in SEQ ID NO.12.
[0036] The nucleotide sequence of the ERG20 gene is shown in SEQ ID NO.13.
[0037] The nucleotide sequence of the UPC2-1 gene is shown in SEQ ID NO.14.
[0038] The nucleotide sequence of the HIF-1α gene is shown in the NCBI database sequence accession number NM_001243084.2.
[0039] The nucleotide sequence of the ARNT gene is shown in the NCBI database sequence accession number NM_001668.4.
[0040] The nucleotide sequence of the NDT80 gene is shown in NCBI database sequence accession number 856524.
[0041] A method for producing β-caryophyllene comprises the following steps:
[0042] (1) transferring the β-caryophyllene synthase gene into an engineered bacterium, inoculating it into a culture medium for cultivation, and adding an extract during the cultivation;
[0043] (2) Cultivate and separate to obtain an extract, and further purify to obtain β-caryophyllene.
[0044] The engineered bacteria described in step (1) is at least one of strains SE-B1, SE-B2 and an engineered strain of Saccharomyces cerevisiae that produces high β-caryophyllene.
[0045] The strain SE-B1 is based on the saccharomyces cerevisiae SE-Y0 as the starting strain, and the fusion fragment obtained by fusing ERG20 and β-caryophyllene synthase genes using (GGGS)2 as a connecting peptide is integrated into the TY1 site of the saccharomyces cerevisiae chromosome and the GAL80 gene is knocked out.
[0046] The engineered strain SE-B2 is obtained by taking strain SE-B1 as the starting strain, knocking out the NDT80 gene in the strain genome, and integrating the HIF-1α and ARNT genes into the position of the original NDT80 gene.
[0047] The engineered yeast of high-yield beta-caryophyllene is obtained by taking strain SE-B1 as the starting strain and integrating tHMGR and UPC2-1 genes into the TY4 site of the chromosome of yeast.
[0048] The extracting liquid in step (1) is n-dodecane, which is added 12 hours after the start of fermentation and in an amount of 10% of the total volume of the fermentation liquid.
[0049] The culture described in step (1) is carried out in a defective SD liquid culture medium at 28 to 32° C. for 1 to 7 days.
[0050] The culture described in step (1) is an induced culture, and when the initial carbon source is exhausted, glucose and galactose are added in a mass ratio of 1:1 for feeding.
[0051] Compared with the prior art, the present invention has the following advantages and effects:
[0052] The present invention is based on the SE00 chassis bacteria with high production of precursor FPP, and fused ERG20 (FPP synthase) and AarTPS88 (β-caryophyllene synthase) through flexible linker (GGGS) 2. The genes HIF-1, UPC2-1 and tHMGR are overexpressed to increase the metabolic flux of the MVA pathway, thereby improving the biosynthesis of β-caryophyllene; the engineered bacteria SE17 producing β-caryophyllene is successfully obtained; the final shake flask yield of β-caryophyllene is 828.4 mg / L. In order to further evaluate the performance of the two engineered bacteria in fermentation tank fermentation, the engineered bacteria SE16 and SE17 were respectively subjected to batch fed fermentation in a 5L bioreactor, and the final titer of β-caryophyllene was 15.6 g / L; among them, the titer of the β-caryophyllene engineered bacteria is the highest titer reported in yeast so far. BRIEF DESCRIPTION OF THE DRAWINGS
[0053] Figure 1 This is a graph showing the GC-MS detection results of the expression products of AarTPS88, AarTPS54, AarTPS78 and AarTPS61.
[0054] Figure 2 This is a graph showing the quantitative analysis results of the expression products of AarTPS88, AarTPS54, AarTPS78 and AarTPS61.
[0055] Figure 3 It is the expression vector map of the fusion plasmid and the plasmid extraction electrophoresis result diagram.
[0056] Figure 4 It is a schematic diagram of the gene construction method in Example 2.
[0057] Figure 5 This is a diagram of the fermentation product detection results of strain SE13.
[0058] Figure 6 It is a schematic diagram of the gene construction method in Example 3.
[0059] Figure 7 This is a diagram of the fermentation product detection results of strain SE15.
[0060] Figure 8 It is a schematic diagram of the gene construction method in Example 4.
[0061] Fig. 9 This is a diagram of the fermentation product detection results of strain SE17.
[0062] Fig.10 This is a graph showing the results of the fed-batch fermentation experiment of β-caryophyllene produced by the engineered bacteria in Example 5. DETAILED DESCRIPTION
[0063] The present invention is further described in detail below in conjunction with embodiments and drawings, but the embodiments of the present invention are not limited thereto.
[0064] If no specific experimental conditions are specified in the following embodiments, conventional experimental conditions or experimental conditions recommended by the reagent company are generally followed. The materials and reagents used, unless otherwise specified, are all reagents and materials obtained from commercial sources.
[0065] Example 1 Screening, vector construction and expression of Artemisia argyi TPSs
[0066] Based on the previous research of our laboratory, several potential terpene synthase (TPS) candidate genes were isolated from the root, stem and leaf tissues of Artemisia argyi of the Asteraceae family. They may have the ability to synthesize β-caryophyllene, namely AarTPS88, AarTPS54, AarTPS78 and AarTPS61. In order to verify their functions, the above genes were integrated into plasmids and transferred into Saccharomyces cerevisiae for expression. The specific steps are as follows:
[0067] 1.1 Construction of vector
[0068] In this experiment, the mugwort cDNA was used as a template to amplify the mugwort AarTPSs candidate genes (AarTPS88, AarTPS78, AarTPS54 and AarTPS61). The reaction system, primer sequences and procedures are shown in Tables 1 to 3. After the amplified target fragments were purified and recovered, the yeast expression vector pESC-URA was double-digested with restriction endonucleases BamHI and NheI from Thermo Fisher Scientific, so that the linearized vector and the purified PCR product had the same sticky ends, as shown in Tables 4 to 5.
[0069] Table 1 Gene amplification system
[0070]
[0071] Table 2 Gene amplification reaction procedure
[0072]
[0073] Table 3 Primers involved in vector construction
[0074]
[0075] Table 4 pESC-URA double restriction enzyme digestion system
[0076]
[0077] The double enzyme digestion system was placed in a PCR instrument and incubated at 37°C for 30 min and 80°C for 5 min to inactivate the enzyme and terminate the reaction. Subsequently, the linearized vector and the purified PCR product were homologously recombined using the ClonExpress II One Step Cloning Kit from Nanjing Novogene. The reaction system is shown in Table 5, and the reaction conditions were 37°C for 30 min.
[0078] Table 5 Homologous recombination reaction system
[0079]
[0080]
[0081] They were inserted into the yeast expression vector pESC-URA between the BamHI and NheI restriction sites under the control of the GAL1 promoter. The recombinant products were then transformed into Escherichia coli DH5α, and the single colonies grown were screened for positive transformants by bacterial liquid PCR, and the plasmids were extracted and sequenced for identification. The identification results showed that four yeast expression vectors were successfully constructed, namely pESC-URA-GAL1p-AarTPS88-CYC1t, pESC-URA-GAL1p-AarTPS78-CYC1t, pESC-URA-GAL1p-AarTPS54-CYC1t, and pESC-URA-GAL1p-AarTPS61-CYC1t.
[0082] 1.2 Transformation and verification of vector
[0083] SE-Y0 was used as the starting strain (this strain was based on CEN.PK2-1C, and Ptef1-ERG1-Tpgk, Padh1-ERG13-Tadh1, Padh1-ERG12-Tadh1, Ptef2-ERG19-Tcyc1, Ppgk-IDI1-Tpgk, Ptdh3-AtCPR1-Ttdh3, Ptef1-ERG10-Tpgk, Ptdh 3-ERG8-Ttdh3, Ppgk-tHMGR-Tadh1, Ptdh3-ERG20+ERG9-Tcyc1, Trp site was transferred into Ptdh3-ERG20+ERG9-Tcyc1, Ptef1-ERG10-Tpgk, Ptdh3-ERG8-Ttdh3, Ppgk-tHMGR-Tadh1, Ptef1-ERG1-Tpgk1, the strain and its preparation method have been described in the literature Wu S, Zhang F, Xiong W, et al. An Unexpected Oxidosqualene Cyclase Active Site Architecture in the Iris tectorum Multifunctional α-Amyrin Synthase[J].
[0084] DOI:10.1021 / acscatal.0c03231.), knocking out the GAL80 gene (knockout method refers to Xie W, Liu M, Lv X, Lu W, Gu J, Yu H. Construction of a controllable β-carotene biosynthetic pathway by decentralized assembly strategy in Saccharomyces cerevisiae. Biotechnol Bioeng. 2014 Jan; 111(1):125-33. doi:10.1002 / bit.25002. Epub 2013 Aug. 12.PMID:23860829.), strain SE00 was obtained, competent yeast cells were prepared, and the plasmids prepared in 1.1 were transferred into competent cells respectively using the lithium acetate chemical transformation method, and spread on the solid culture medium of SD-Ura. After waiting for 2 to 3 days, when a single clone grew out, the positive single clone colony was picked, and PCR sequencing was performed to verify whether the target gene was successfully transformed. After verification, four engineered bacteria, SE04 (AarTPS88), SE05 (AarTPS78), SE06 (AarTPS54), and SE07 (AarTPS61), were obtained.
[0085] 1.3 Shake flask fermentation
[0086] Pick 3 positive transformants from the propagation plate of the engineered bacteria obtained in 1.2 into a shaking tube containing 3 mL of SD medium with the corresponding screening marker, and culture overnight at 30°C, 200 rpm to form a seed solution. Inoculate the seed solution into a shaking flask containing 50 mL of SD-Ura medium at an inoculum volume of 1% (v / v), add galactose to induce expression, and add 5 mL of n-dodecane extractant (to avoid volatilization of metabolites during the induction of expression), and culture on a yeast shaker for 5 days.
[0087] After the shake flask fermentation was completed, the fermentation broth and the extractant were placed in a 50 mL centrifuge tube and centrifuged at 5000 rpm for 5 min. The upper n-dodecane organic phase was aspirated and appropriately diluted with n-hexane and filtered. The metabolites in the dilution were then detected using GC-MS.
[0088] Preparation of standard curve: using n-dodecane as solvent, a 10 mg / mL β-caryophyllene standard stock solution was prepared, and then 0.02 mg / mL, 0.04 mg / mL, 0.06 mg / mL, 0.08 mg / mL, and 0.1 mg / mL β-caryophyllene standard solutions were prepared according to different dilution ratios, and they were placed in injection vials for GC-MS detection; the β-caryophyllene concentration and peak area data were processed to obtain a standard curve of β-caryophyllene for subsequent quantitative analysis of β-caryophyllene samples.
[0089] 1.4 Results and Discussion
[0090] The experimental results are as follows Figure 1 As shown in the figure, the GC-MS analysis results of the expression products of AarTPS88, AarTPS54, AarTPS78 and AarTPS61 showed that compared with the empty vector control, the four synthases had two new product peaks, among which there was a main product peak P1 at 16.66min, which matched the retention time and mass spectrum data of the β-caryophyllene standard. In addition, there was a minor product P2 at 17.09min, which was found to have the same retention time and mass spectrum as the α-caryophyllene standard; thus, these four synthases were determined to be β-caryophyllene synthases encoding β-caryophyllene; this was consistent with the results of their clustering with β-caryophyllene synthases in phylogenetic analysis. The quantitative analysis results of the products by GC-MS showed that AarTPS88 had the highest β-caryophyllene production, and the shake flask production of strain SE04 was 111.3mg / L, so AarTPS88 was selected for subsequent experiments.
[0091] Example 2 Construction of an engineered strain expressing ERG20
[0092] 2.1 Construction of fusion plasmid
[0093] In this experiment, (GGGS)2 was selected as the connecting peptide to construct the ERG20 (farnesyl pyrophosphate synthase) and β-caryophyllene-producing AarTPSs fusion plasmid.
[0094] First, using ERG20-(GGGS)2 plasmid as a template, primers ERG20-F and ERG20-(GGGS)2-AarTPS88-R in Table 6 were used to amplify the first half of the target fragment ERG20-(GGGS)2-AarTPS88, ERG20-(GGGS)2 (SEQ ID NO. 9).
[0095] Next, the second half fragment (GGGS)2-AarTPS88 was amplified using primers ERG20-(GGGS)2-AarTPS88-F and pESC-URA-AarTPS88-R using pESC-URA-AarTPS88-obtained in Example 1 as a template.
[0096] Then, the front and back fragments were subjected to overlapping PCR experiments through homology arms. The specific steps of overlapping PCR were as follows: referring to the reaction system in Table 1, 1uL of ERG20-(GGGS)2 and (GGGS)2-AarTPS88 were added to the gene amplification system in equal amounts, and placed in a PCR instrument according to the amplification program in Table 2 to react and obtain the overlapping fragment ERG20-(GGGS)2-AarTPS88.
[0097] Referring to the method of Example 1, ERG20-(GGGS)2-AarTPS88 was inserted into the yeast expression vector pESC-URA between the BamHI and NheI restriction sites under the control of the GAL1 promoter. The positive transformants after correct sequencing were subjected to plasmid extraction experiments to obtain the plasmid pESC-URA-ERG20-(GGGS)2-AarTPS88. The plasmid map is shown in FIG. Figure 3 As shown in A, the electrophoresis results after plasmid extraction are as follows Figure 3 As shown in B.
[0098] 2.2 Construction of recombinant fragments
[0099] Using plasmid pCfb2988 as a template, the TY1-TRP-UP end of the fragment was amplified using primers pTY1-TRP-ERG20-UP-F and pTY1-ERG20-(GGGS)2-R in Table 6, and the TY1-TRP-DOWN end of the fragment was amplified using primers pTY1-TRP-ERG20-DOWN-F and pTY1-TRP-ERG20-DOWN-R.
[0100] The fusion plasmid pESC-URA-ERG20-(GGGS)2-AarTPS88 obtained in 2.1 was used as a template and primers were used to amplify the fragment TY1-TRP-AarTPS88 (TRP-GAL1p-ERG20-(GGGS)2-AarTPS88-CYC1t. The specific construction can be referred to Figure 4 ).
[0101] Table 6 Primers involved in fusion expression of ERG20
[0102]
[0103] 2.3 Product expression and detection
[0104] The target fragment obtained in 2.1 was purified and recovered. Referring to the method in Example 1, yeast strain SE00 was used as the starting strain, and engineered strain SE13 was obtained through transformation and screening, and then induced to express the product.
[0105] The products after induced expression were detected and quantitatively analyzed by GC-MS. The results are shown in Figure 5 .Depend on Figure 5 It can be seen that the shake flask yield of the β-caryophyllene-producing strain SE13 obtained after fusion expression was 320.6 mg / L, which was 2.9 times higher than that of the strain SE04.
[0106] Example 3 Construction of an engineered strain overexpressing HIF-1
[0107] 3.1 Construction of recombinant fragments
[0108] In order to further increase the yield of β-caryophyllene in strain SE13, this experiment further overexpressed the gene of hypoxia-inducible factor-1 (HIF-1) complex in the strain. The specific steps are as follows:
[0109] Using the yeast genome of strain CEN.PK2-1C as a template, PCR amplification was performed by pairing NDT80-UP-F and NDT80-UP-R, NDT80-DOWN-F and NDT80-DOWN-R in Table 7 to obtain NDT80-UP and NDT80-DOWN fragments.
[0110] Using the plasmid pTP-URA-HIF-1α-ARNT as a template (the plasmid and its preparation method have been disclosed in the literature Lin, X., An, T., Fu, D. et al. Optimization of central carbon metabolism by Warburg effect of human cancer cell improves triterpenes biosynthesis in yeast. Adv. Biotechnol. 1, 4 (2023).), primers NDT80-ADH1t-F and NDT80-CYC1t-R were used to amplify the NDT80-PGK1p-HIF-1α-CYC1t-TEF1p-ARNT-ADH1t fragment.
[0111] Table 7 Primers involved in overexpression of HIF-1
[0112]
[0113] 3.2 Product expression and detection
[0114] The three fragments obtained in 3.1 were purified and recovered, and were transferred into the yeast strain SE13 obtained in Example 2 together with the Cas9 plasmid pCRCT-GTR-URA3-△NDT80 (the construction method of the plasmid is referred to the literature Zhang, Y., Wang, J., Wang, Z. et al. A gRNA-tRNA array for CRISPR-Cas9 based rapid multiplexed genome editing in Saccharomyces cerevisiae. Nat Commun 10, 1053 (2019). https: / / doi.org / 10.1038 / s41467-019-09005-3, the plasmid backbone pCRCT was purchased from Newpro Bio, and the gRNA sequence is shown in SEQ ID NO.11) according to the method of Example 1 (the specific construction method can be referred to Figure 6 ), after transformation and screening, engineered bacteria SE15 was obtained, and then induced to express the product.
[0115] The experimental results are as follows Figure 7 As shown, the β-caryophyllene production of strain SE15 obtained by heterologous expression of the HIF-1 gene reached 713.6 mg / L in a shake flask, which was 2.2 times higher than that of strain SE13.
[0116] Example 4 Optimization of the MVA pathway to improve the biosynthesis of β-caryophyllene
[0117] 4.1 Construction of recombinant fragments
[0118] In order to further increase the yield of β-caryophyllene in strain SE15, this experiment further optimized the MVA pathway to improve the biosynthesis of β-caryophyllene. The expression cassettes containing the tHMGR and UPC2-1 genes were integrated into the TY4 multi-copy site of the genome of strains SE14 and SE15 by multi-fragment homologous recombination. The specific steps are as follows:
[0119] Using plasmid pCfb2798 as a template, PCR amplification was performed using primers pTY4-LEU2-UP-F and pTY4-LEU2-UP-R, pTY4-LEU2-DOWN-F and pTY4-LEU2-DOWN-R in Table 8, respectively, to obtain TY4-LEU2-UP end and TY4-LEU2-DOWN end fragments.
[0120] Using plasmid pESC-URA-tHMGR-UPC2-1 as a template, primers pTY4-LEU2-ADH1t-F and pTY4-LEU2-CYC1t-R were used to amplify the TY4-LEU2-tHMGR-UPC2-1 (LEU2-GAL10p-tHMGR-ADH1t-GAL1p-UPC2-1-CYC1t) fragment.
[0121] Table 8 Optimization of primers involved in the MVA pathway
[0122]
[0123] 4.2 Product expression and detection
[0124] The three fragments obtained in 4.1 were purified and recovered. Referring to the method of Example 1, strain SE15 was used as the starting strain, and engineered strain SE17 was obtained through transformation and screening, and then induced to express the product.
[0125] The experimental results are as follows Fig. 9 As shown, the β-caryophyllene production of strain SE17 was 828.4 mg / L, which was 16% higher than that of strain SE15.
[0126] Example 5 Fed-batch fermentation of engineered bacteria
[0127] To evaluate the potential of engineered strain SE17 as a β-caryophyllene cell factory, fed-batch fermentation was performed in a 5 L bioreactor with the following steps:
[0128] (1) Pick a single colony with verified function from the propagation plate and place it in 3 mL of SD medium with the corresponding screening marker and culture it at 30°C with shaking at 200 rpm for 24 h;
[0129] (2) Transfer 500 μL of bacterial solution to a shake flask containing 50 mL of SD defective medium and culture at 30°C and 200 rpm for 24 h;
[0130] (3) Finally, the inoculum was transferred to 200 mL SD defective medium at a 1% (v / v) inoculation amount, and cultured at 30°C and 200 rpm for 24 h. The bacterial solution obtained was added to the fermenter as a seed solution. The relevant parameters of the fermenter were: fermentation temperature 30°C, ventilation 2 L / min, pH was maintained at 5.5 by automatically adding ammonia water during the fermentation process, and DO (dissolved oxygen) was maintained at about 40% by adjusting the stirring speed. When the initial carbon source was exhausted, feeding (glucose: galactose = 1:1) was started to maintain cell growth and induced expression;
[0131] (4) After 12 hours of fermentation, 10% volume of n-dodecane solvent was added to the tank, and the fermentation was continued for a total of 120 hours. After the fermentation was completed, the fermented bacteria and the upper organic phase were collected by centrifugation for subsequent separation and purification of the product. The formula of the fermentation tank and the feed medium is shown in the following table:
[0132] Table 9 Fermentation tank medium formula
[0133]
[0134] Table 10 Trace element solution composition
[0135]
[0136]
[0137] Table 11 Vitamin solution composition
[0138]
[0139] The difference of this experiment is that when the initial carbon source is completely consumed, ethanol is used as the carbon source for feeding, and bacterial samples are taken every 12 hours, and then the cell density (OD 600 ) measurement and GC-MS analysis, the experimental results are as follows Fig.10 The results showed that due to the addition of n-dodecane, the cell growth of engineered strain SE17 was slightly inhibited in the first 24 hours, but it grew rapidly in the later period; the cell density (OD 600 ) reached a maximum value of 314, at which time the titer of β-caryophyllene finally reached 15.6 g / L, which is the highest β-caryophyllene titer reported in yeast so far.
[0140] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. A β-caryophyllene synthase, It is characterized by At least one of the following: (a) a protein consisting of an amino acid sequence as shown in at least one of SEQ ID NO.1, SEQ ID NO.3, SEQ ID NO.5 and SEQ ID NO.7; (b) a sequence having a sequence homology of more than 90% with at least one of the amino acid sequences shown in SEQ ID NO.1, SEQ ID NO.3, SEQ ID NO.5 and SEQ ID NO.7 and having the same protein function.
2. The β-caryophyllene synthase according to claim 1, Features: The β-caryophyllene synthase encoding gene is a nucleotide sequence shown by at least one of SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.
8.
3. An engineered strain of Saccharomyces cerevisiae that produces high levels of β-caryophyllene, Features: Using Saccharomyces cerevisiae as the starting strain, the GAL80 gene was knocked out, the tHMGR and UPC2-1 genes were introduced, the NDT80 gene was knocked out and the HIF-1α and ARNT genes were overexpressed, and the ERG20 gene and β-caryophyllene synthase gene were introduced to obtain it.
4. The engineered yeast of claim 3, Features: The said transfer of tHMGR and UPC2-1 genes is to integrate tHMGR and UPC2-1 genes into the TY4 site of the Saccharomyces cerevisiae chromosome; The ERG20 gene and β-caryophyllene synthase gene are introduced using (GGGS) 2 After fusing ERG20 with β-caryophyllene synthase gene as a connecting peptide to obtain a fusion fragment, the fusion fragment was integrated into the TY1 site of the Saccharomyces cerevisiae chromosome; The knockout of NDT80 gene and overexpression of HIF-1α and ARNT genes is to knock out the NDT80 gene in the Saccharomyces cerevisiae genome and integrate the HIF-1α and ARNT genes into the original position of the NDT80 gene.
5. A β-caryophyllene synthase gene, which can be introduced into Saccharomyces cerevisiae to produce β-caryophyllene, Features: The amino acid sequence thereof is at least one of SEQ ID NO.2, SEQ ID NO.4, SEQ ID NO.6 and SEQ ID NO.
8.
6. Use of the β-caryophyllene synthase according to any one of claims 1 to 2, the engineered bacteria according to any one of claims 3 to 4, and the β-caryophyllene synthase gene according to claim 5 in producing β-caryophyllene.
7. A method for constructing an engineered strain of Saccharomyces cerevisiae that produces high levels of β-caryophyllene. Features The steps include: (1) Using Saccharomyces cerevisiae as the starting strain, the GAL80 gene was knocked out to obtain strain SE-B0; (2) GAL1p promoter, ERG20 gene, (GGGS) 2 The connecting peptide, β-caryophyllene synthase gene and CYC1t terminator were sequentially connected to construct a fusion fragment, which was integrated into the TY1 site of the genome of strain SE-B0, and strain SE-B1 was obtained after screening; (3) The PGK1p promoter, HIF-1α gene, CYC1t terminator, TEF1p promoter, ARNT gene and ADH1t were sequentially connected to construct the PGK1p-HIF-1α-CYC1t-TEF1p-ARNT-ADH1t fragment, the NDT80 gene in the genome of strain SE-B1 was knocked out, and the fragment was integrated into the position of the original NDT80 gene. After screening, strain SE-B2 was obtained; (4) The GAL10p promoter, tHMGR gene, ADH1t terminator, GAL1p promoter, UPC2-1 gene and CYC1t terminator were sequentially connected to construct the GAL10p-tHMGR-ADH1t-GAL1p-UPC2-1-CYC1t fragment, which was integrated into the TY4 site of strain SE-B2, and an engineered Saccharomyces cerevisiae strain with high β-caryophyllene production was obtained after screening.
8. The construction method according to claim 7, Features: The (GGGS) 2 The nucleotide sequence of the connecting peptide is shown in SEQ ID NO.10; The integration is to transform the fragment into the cell using the lithium acetate transformation method, and the fragment is transferred together with the positioning fragment containing the homologous fragment and the screening marker, and integrated with the target site through homologous recombination.
9. The β-caryophyllene synthase according to any one of claims 1 to 2, the engineered bacteria according to any one of claims 3 to 4, the β-caryophyllene synthase gene according to claim 5, and the construction method according to any one of claims 7 to 8, Features: The Saccharomyces cerevisiae described is an engineered strain SE-Y0, which has been disclosed in the literature Wu S, Zhang F, Xiong W, et al. An Unexpected Oxidosqualene Cyclase Active Site Architecture in the Iristectorum Multifunctional α-Amyrin Synthase [J]. DOI: 10.1021 / acscatal.0c03231. The nucleotide sequence of the GAL80 gene is shown in NCBI database sequence accession number 854954; The nucleotide sequence of the tHMGR gene is shown in SEQ ID NO.12; The nucleotide sequence of the ERG20 gene is shown in SEQ ID NO.13; The nucleotide sequence of the UPC2-1 gene is shown in SEQ ID NO.14; The nucleotide sequence of the HIF-1α gene is shown in the NCBI database sequence accession number NM_001243084.2; The nucleotide sequence of the ARNT gene is shown in the NCBI database sequence accession number NM_001668.4; The nucleotide sequence of the NDT80 gene is shown in NCBI database sequence accession number 856524.
10. A method for producing β-caryophyllene, Features The steps include: (1) transferring the β-caryophyllene synthase gene into an engineered bacterium, inoculating it into a culture medium for cultivation, and adding an extract during the cultivation; (2) Cultivate and separate to obtain an extract, and further purify to obtain β-caryophyllene.
Citation Information
Patent Citations
A method of synthesizing beta-caryophyllene by microbial catalysis and a reconstituted cell capable of synthesizing the beta-caryophyllene
CN104120141A
Beta-caryophyllene synthetase as well as gene, strain and application thereof
CN116286767A
Cited By
Application of AaTPS gene in regulation and control of plant seed size
CN121046358A
Use of AaTPS gene in regulating plant seed size
CN121046358B
